| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $63.8M | +17.6% |
| SG&A Expense | $37.0M | +129.6% |
| Operating Income | -$100.8M | -43.3% |
| Income Tax | $1K | +0.0% |
| Net Income | -$85.9M | -24.7% |
| EPS (Basic) | -$0.91 | -1.1% |
| EPS (Diluted) | -$0.91 | -1.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.5M | +51.6% |
| Current Assets | $367.2M | +119.8% |
| Total Assets | $368.5M | +118.7% |
| Current Liabilities | $19.1M | -12.8% |
| Total Liabilities | $20.1M | -13.5% |
| Stockholders' Equity | $348.4M | +139.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.4M | -51.6% |
| Investing Cash Flow | -$179.1M | -427.1% |
| Financing Cash Flow | $271.4M | +6418.8% |